Mondias announces agreement with Wisdom of Nature Brokerage to expand retail sales in Ontario and grants stock options

MONTREAL, Jan. 25, 2019 /CNW/ – Mondias Natural Products Inc (“Mondias” or “Company”), (TSX VENTURE: NHP) announces the signing of a sales representation agreement with Wisdom of Nature Brokerage, a company specializing in the retail sales of Natural Health Products in Ontario. Mondias through its recently acquired Holizen brand, has been operating successfully in the province of Quebec and is now expanding retail operations to Ontario for the first phase of its Canada wide distribution.

Other news

The Board of Directors of the Company has approved, at a meeting held on January 22, the granting of 2,550,000 stock options to directors, officers, consultants and employees of the Company. The exercise price of the options is $0.235 (the closing price of the shares on January 21, 2019). The options vest over a 3-year period and have an expiry date of January 22, 2029.

The above-mentioned options have been granted pursuant to the Mondias’s Stock Option Plan. Following this stock option grant the Company has a total of 2,950,804 stock options outstanding, which represents less than 5% of the Company’s issued and outstanding common shares.

About Wisdom of Nature Inc.

With more than 25 years of experience in the Natural Health Food Industry, Wisdom of Nature, led by its president and CEO Corine Johnson, specializes in sales development and independent/mass market product listing across the province of Ontario. They represent top brands like Strauss, Joy of the Mountain, Nature’s Aid, Abundance Naturally, Cannanda and Pro Santé.

About Mondias Natural Products Inc.

Mondias specializes in the commercialization and development of evidence based botanical products for the health care and bio agriculture markets. The company is already selling both oral and topical botanical agents to help manage unmet medical needs through Holizen Laboratories, one of its divisions. Mondias is also developing botanical based specialty fertilizers for use on household plants, urban gardens, lawns, golf courses, nurseries or greenhouses in collaboration with McGill’s Faculty of Agricultural and Environmental Sciences.

For more information, visit : mondias.ca

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, the success of the Company’s research and development strategies, the success of this joint venture,  the ability to obtain orphan drug status, the applicability of the discoveries made therein, the successful and timely completion and uncertainties related to the regulatory process, the timing of clinical trials, the timing and outcomes of regulatory or intellectual property decisions and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. While no definitive documentation has yet been signed by the parties and there is no certainty that such documentation will be signed. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Leave a Reply

Your email address will not be published. Required fields are marked *